Delivery Order HHSN261201200014I-HHSN26100001
- This is a federal contract award from the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to SRI International, a non-profit research and development institute. The contract, worth $21,593,775.02, is for "PRECLINICAL PHARMACOLOGICAL STUDIES OF ANTITUMOR AND OTHER THERAPEUTIC AGENTS" and was awarded on December 15, 2004 with a completion date of December 14, 2012. The contract type is Definitive Contract with a Cost Plus Fixed Fee pricing...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $287,312.00 cost-plus-fixed-fee delivery order contract to Sri International, a non-profit research institute, for a "Tissue Cross-Reactivity Study of a Human Antibody." This contract is under the parent "Toxicology of Drugs Developed for Cancer Patients" indefinite delivery vehicle (IDV). Sri International has a history of providing research, development, and...
- This is a federal contract awarded by the National Cancer Institute, a component of the Department of Health and Human Services, to SRI International, a non-profit research and development institute. The contract is for the synthesis of non-GMP (non-Good Manufacturing Practice) small molecules, with a total ceiling value of $5,499,854.59. The contract type is Cost Plus Fixed Fee, and the ultimate completion date is June 30, 2012. SRI International has a history of supporting federal agencies...
- This is a $7,910,623.00 cost-plus-fixed-fee contract awarded by the National Cancer Institute (part of the U.S. Department of Health and Human Services) to SRI International, a non-profit research and development institute. The contract is for analysis of anti-cancer chemicals and pharmaceutical formulations. It does not have a small business set-aside designation. SRI International frequently serves as a prime contractor and subcontractor on research and development contracts and grants with...
- This federal contract award is for a task order issued under the "Nonclinical Services for Development of Interventional Agents" indefinite delivery, indefinite quantity (IDIQ) contract. The prime contractor is Sri International, a non-profit research and development institute. The contract has a ceiling value of $5,875.97 and was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services (HHS). The task...
- This is a $67,787,765.29 cost-plus-fixed-fee contract awarded by the National Cancer Institute (NCI) to SRI International, a non-profit research and development institute, for preclinical toxicology and pharmacology of drugs. The contract supports biomedical research and drug development services for the NCI. SRI International has multiple indefinite delivery vehicles (IDVs) with federal agencies like the Department of Defense, NASA, and the National Institutes of Health that enable efficient...
- This is a $748,053.07 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Child Health and Human Development, a civilian agency within the U.S. Department of Health and Human Services. The contract was awarded to Sri International, a non-profit research and development institute, to conduct medical and biomedical applied research and exploratory development. This work falls under the agency's Biological Testing Facility major program. The contract does not have a...
- This is a delivery order contract award to SRI International, a non-profit research and development institute, by the National Institute of Child Health and Human Development (NICHD), a component of the U.S. Department of Health and Human Services. The $897,528.98 award is for a task order under the Biological Testing Facility contract vehicle, which covers clinical manufacturing, formulation development, and stability testing services. The award does not have a small business set-aside. SRI...
- This is a $756,613.00 firm fixed-price delivery order awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the Department of Health and Human Services (HHS), to Sri International, a non-profit research and development institute. The award is for Task Order #001 under the Pharmacology and Toxicology for Therapeutics Program (PTTP) master indefinite delivery/indefinite quantity (IDIQ) contract, and covers management and operations support...
- This is a federal contract award to Sri International, a non-profit research and development institute, by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services (HHS). The contract, a Delivery Order with a cost plus fixed fee pricing type, is for pre-clinical services to support the development of interventional agents for infectious diseases. The contract has a ceiling value of $5,491,527.88 and a period of...
- HHSN261201200014IIndefinite Delivery Contract
- HHSN261201200014I-HHSN26100001Delivery Order
This federal contract award is for an "OTHER FUNCTIONS - CONTRACT ORIENTATION MEETING WITH NCI, OFFICE OF ACQUISITIONS" valued at $4,144.00. The award was made by the National Cancer Institute (NCI), which is part of the U.S. Department of Health and Human Services, to the prime contractor Sri International, a non-profit research and development institute. The contract is a Delivery Order under the Preclinical Efficacy and Intermediate Endpoint Biomarkers contract vehicle. Sri International provides a wide range of scientific, engineering, and technical services to federal government agencies through contracts and grants, including substantial biomedical research for the Department of Health and Human Services. This award does not have a small business set-aside designation.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Preclinical Efficacy and Intermediate Endpoint Biomarkers | N01CN25002-78 | Department of Health and Human Services National Institutes of Health | Award Notice 2/3 | 2/27/12, 1:10 PM | |
Preclinical Efficacy and Intermediate Endpoint Biomarkers | N01CN25002-78 | Department of Health and Human Services National Institutes of Health | Award Notice 3/3 | 3/13/12, 3:37 PM | |
Preclinical Efficacy and Intermediate Endpoint Biomarkers | N01CN25002-78 | Department of Health and Human Services National Institutes of Health | Award Notice 1/3 | 12/15/11, 3:10 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 3 | Other Administrative Action | ($497) | 2/25/16 | |
| 2 | Other Administrative Action | $0 | 12/10/13 | |
| 1 | Other Administrative Action | $0 | 5/20/13 | |
| Not listed | Not listed | $4.1k | 9/20/12 |